‘Electronic nose’ aims to help reduce prescribing of antibiotics
Experts have created a machine that sniffs out bacteria
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.The prescribing of antibiotics could be drastically reduced by a device that detects bacteria in human breath, scientists have said.
Experts have created a machine that sniffs out bacteria – meaning it can tell when antibiotics are needed as a treatment.
They said the technology also means patients who present at GP surgeries with respiratory tract infections can be told they have the common cold or the flu.
It analyses the breath sample after a patient has blown into a breathing tube, like they would with a police breathalyser.
Certain chemicals are then identified, signalling whether or not bacteria is present.
Warwick University‘s Professor James Covington, who developed the “electronic nose”, said he hopes it will one day help reduce the number of antibiotic prescriptions.
He said: “I want to try and make the drugs we have last longer. Our idea is that we are going to get breath, and we are going to sniff it. Smelling breath gives access to the body’s biological process. We are trying to reduce the number of people being prescribed medication – if you can reduce this by 20 per cent, that is a massive saving.”
Preliminary trial results from the BreathSpec project, which was led by Imspex, suggest it has 80 per cent accuracy, Prof Covington told the British Science Festival, which is being held in Coventry and Warwickshire.
Over 18 months, the scientists recruited 1,112 participants from seven hospitals and two GP surgeries – two hospitals and two GP surgeries in Liverpool, two hospitals in Leicester and hospitals in Cardiff, Edinburgh and Blackpool.
They found that of these, 406 had an upper respiratory infection, of which 376 were non-bacterial and 30 were bacterial.
There were 520 people with lower respiratory infection, 272 of which were non-bacterial and 248 were bacterial. Some 186 had neither.
Prof Covington said: “In essence, we were about 80 per cent accurate – we could tell 80 per cent of patients who did not have bacterial infections. This could be a cold or a flu or one of the other ones – that is pretty good for a general screening situation.
“But to an extent, you could also say that we could accurately state that eight out of 10 patients had the flu or common cold.”
Press Association
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments